GlycoEra is a Biotech company based in Schlieren, Switzerland. It has raised $179M in total funding. Latest round: Series B.
GlycoEra funding overview
GlycoEra is a Biotech company based in Schlieren, Switzerland. GlycoEra has raised $179M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in January 2024. The round record for GlycoEra runs through 2024; nothing later has been disclosed. Investors on record include Novo Holdings, Catalio Capital Management, LifeArc Ventures, Qatar Investment Authority, Sofinnova Partners, 5AM Ventures and 2 others. 8 distinct backers are named across the disclosed rounds.
GlycoEra at a glance
Total raised
$179M
Latest round
Series B
Latest round date
January 2024
Industry
Biotech
Headquarters
Schlieren, Switzerland
Notable investors
Novo Holdings, Catalio Capital Management, LifeArc Ventures, Qatar Investment Authority, Sofinnova Partners, 5AM Ventures, Roche Venture Fund, Bristol Myers Squibb
Frequently asked about GlycoEra funding
How much has GlycoEra raised?
GlycoEra has raised $179M in total disclosed funding across the rounds on record.
Who has invested in GlycoEra?
Novo Holdings, Catalio Capital Management, LifeArc Ventures, Qatar Investment Authority, Sofinnova Partners, 5AM Ventures are named among the investors backing GlycoEra.
What was the latest GlycoEra funding round?
The most recent disclosed round is a Series B, announced in January 2024.
Where is GlycoEra based?
GlycoEra is based in Schlieren, Switzerland.
What sector does GlycoEra operate in?
GlycoEra is tracked under Biotech from Schlieren, Switzerland, with $179M in disclosed funding.
When did GlycoEra last raise?
The last disclosed GlycoEra round closed in January 2024 at Series B.
GlycoEra totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Schlieren below to benchmark round size and investor mix.
